SECURITIES
AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549

FORM
10-QSB

[   ] QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES ACT OF 1934

For  the
quarterly period ended March 31, 2006.

[X]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE
ACT OF 1934

Commission
File Number 000-51386

EAST
WEST DISTRIBUTORS, INC.(EXACT NAME
OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

|NEVADA                          | 20-2012723
|------------------------------- | ----------
|(State or other jurisdiction of |           
|Incorporation or organization)  |           
|                                |           

PMB
38210105 East Via Linda, #103Scottsdale, AZ 85258(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)

(480)
614-2874(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)

SECURITIES
REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:NONE

SECURITIES REGISTERED
PURSUANT TO SECTION 12(G) OF THE ACT:COMMON STOCK, $ .001 PAR VALUE



INDICATE
BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED TO BE
FILED BY SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING THE
PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED
TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR
THE PAST 90 DAYS.

YES    X     NO

ON
March 31, 2006, THERE WERE 2,456,855 SHARES OF THE ISSUERS COMMON STOCK
OUTSTANDING.

TRANSITIONAL
SMALL BUSINESS DISCLOSURE FORMAT (CHECK ONE):  YES    X     NO

DOCUMENTS
INCORPORATED BY REFERENCE

NONE.



---

INDEX

|Part I  Financial Information | PAGE NO.
|------------------------------ | --------
|                               | Item 1. 
|                               |         
|                               |         
|                               |         
|                               |         
|                               |         
|                               |         
|                               |         
|                               |         
|                               |         
|                               |         
|                               |         
|                               |         
|                               | Item 2. 
|                               |         
|                               | Item 3. 
|                               |         
|Part II   Other Information   |         
|                               |         
|                               | Item 1. 
|                               |         
|                               | Item 2. 
|                               |         
|                               | Item 3. 
|                               |         
|                               | Item 4. 
|                               |         
|                               | Item 5. 
|                               |         
|                               | Item 6. 
|                               |         

This
amended 10QSB for the quarter ended March 31, 2006 includes revised footnotes
and revised Statements of Operations and Cash Flows. None of the changes are
deemed to be material.

2



---

EAST WEST
DISTRIBUTORS, INC.(A Development Stage Company)Balance SheetMarch 31, 2006

(Unaudited)

|                                                        | 
|------------------------------------------------------- | 
|Assets                                                  | 
|                                                        | 
|Cash in Bank                                            | 
|                                                        | 
|Total Assets                                            | 
|                                                        | 
|                                                        | 
|                                                        | 
|Liabilities and Shareholders' Deficit                   | 
|                                                        | 
|Current Liabilities                                     | 
|Accrued expenses and payables to directors and officers | 
|Due to related party                                    | 
|                                                        | 
|                                                        | 
|Total Current Liabilities                               | 
|                                                        | 
|                                                        | 
|Total Liabilities                                       | 
|                                                        | 
|Shareholders' Deficit                                   | 
|Preferred stock, $0.001 par value; 25,000,000 shares    | 
|and no shares issued and outstanding                    | 
|Common stock. $0.001 par value; 400,000,000 shares      | 
|authorized, 2,456,855 shares issued and outstanding     | 
|Deficit accumulated during development stage            | 
|                                                        | 
|                                                        | 
|Total Shareholders' Deficit                             | 
|                                                        | 
|                                                        | 
|Total Liabilites and Shareholders' Deficit              | 
|                                                        | 
|                                                        | 
|                                                        | 
|                                                        | 

F-1



---



EAST WEST
DISTRIBUTORS, INC.(A Development Stage Company)

STATEMENT OF
OPERATIONS

|                                    | Three months endedMarch 31, 2006 | Nine months endedMarch 31,2006 | From Inception(December 13,2004) ToMarch 31,2006
|----------------------------------- | -------------------------------- | ------------------------------ | ------------------------------------------------
|
|
|Professional Services               |                                  | 5,814                          |                                                 
|Administrative Expenses             |                                  | 301                            |                                                 
|                                    |                                  |                                |                                                 
|                                    |                                  |                                |                                                 
|Total Operating Expenses            |                                  | 6,115                          |                                                 
|                                    |                                  |                                |                                                 
|                                    |                                  |                                |                                                 
|Other Income:                       |                                  |                                |                                                 
|Sale of Biotech                     |                                  |                               |                                                 
|                                    |                                  |                                |                                                 
|                                    |                                  |                                |                                                 
|Total Other Income                  |                                  |                               |                                                 
|                                    |                                  |                                |                                                 
|                                    |                                  |                                |                                                 
|Net Income (Loss)                   |                                  | 6,115                          |                                                 
|                                    |                                  |                                |                                                 
|                                    |                                  |                                |                                                 
|Basic and Diluted Loss Per Share    |                                  |                               |                                                 
|                                    |                                  |                                |                                                 
|Weighted Average shares outstanding |                                  | 2,156,855                      |                                                 
|                                    |                                  |                                |                                                 
|                                    |                                  |                                |                                                 
|                                    |                                  |                                |                                                 

F-2



---

EAST WEST
DISTRIBUTORS, INC.(A Development Stage Company)STATEMENT OF CHANGES IN SHAREHOLDERS'
DEFICIT

|                                   | Number of CommonShares | Common Stock at$.001 Par Value | Deficit Accumulatedduring developmentstage | Total Shareholders'Deficit
|---------------------------------- | ---------------------- | ------------------------------ | ------------------------------------------ | --------------------------
|
|
|Inception December 13, 2004        |                        | 0                              |                                            | $                        
|                                   |                        |                                |                                            |                           
|Distribution of shares in spin-off |                        | 2,156,855                      |                                            | 2,157                     
|                                   |                        |                                |                                            |                           
|Shares used for compensation       |                        | 300,000                        |                                            | 300                       
|                                   |                        |                                |                                            |                           
|Net Loss                           |                        |                                |                                            |                           
|                                   |                        |                                |                                            |                           
|                                   |                        |                                |                                            |                           
|Balance 9/30/05                    |                        | 2,456,855                      |                                            | 2,457                     
|                                   |                        |                                |                                            |                           
|Net Income                         |                        |                                |                                            |                           
|                                   |                        |                                |                                            |                           
|                                   |                        |                                |                                            |                           
|Balance 12/31/05                   |                        | 2,456,855                      |                                            | 2,457                     
|                                   |                        |                                |                                            |                           
|Net Loss                           |                        |                                |                                            |                           
|                                   |                        |                                |                                            |                           
|                                   |                        |                                |                                            |                           
|Balance 3/31/06                    |                        | 2,456,855                      |                                            | $      2,457              
|                                   |                        |                                |                                            |                           
|                                   |                        |                                |                                            |                           
|                                   |                        |                                |                                            |                           

F-3



---

EAST WEST
DISTRIBUTORS, INC.(A Development Stage Company)STATEMENT OF CASH FLOW

|                                       | Nine Months endedMarch 31,2006 | From Inception(December 13,2004) ToMarch 31, 2006
|-------------------------------------- | ------------------------------ | -------------------------------------------------
|
|
|CASH FLOWS FROM OPERATING ACTIVITIES   |                                |                                                  
|                                       |                                |                                                  
|Net Loss                               |                                | $    (55,999                                     
|                                       |                                |                                                  
|Adjustments to reconcile net loss to   |                                |                                                  
|net cash used in operations            |                                |                                                  
|Shares used for compensation           |                                | 300                                              
|                                       |                                |                                                  
|Change in Operating Liabilities        |                                |                                                  
|Due to related party                   |                                | 42,760                                           
|Accrued Expenses and other liabilities |                                | 15,804                                           
|                                       |                                |                                                  
|                                       |                                |                                                  
|Net Cash Used in Operations            |                                | 2,865                                            
|                                       |                                |                                                  
|                                       |                                |                                                  
|CASH                                   |                                |                                                  
|Begnning of period                     |                                |                                                 
|End of period                          |                                | $        2,865                                   
|                                       |                                |                                                  
|                                       |                                |                                                  
|                                       |                                |                                                  

F-4



---

EAST
WEST DISTRIBUTORS, INC.

(Development
Stage Companies)

NOTES
TO FINANCIAL STATEMENTS

MARCH 31,
2006

(Unaudited)

NOTE A
 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business
activity (Company and Subsidiaries)

EAST
WEST Distributors, Inc. (EAST WEST) is a drug development company,
which is focused in the areas of research, development, and marketing in the
biomedical industry, with an emphasis on anti-infective drugs. EAST WEST was
incorporated in Nevada on December 13, 2004. Since then, it has been engaged in
attempting to fund operations with the objective of bringing its future products
to market.

Development
Stage Enterprise

The
Company was formed in December 2004 as a wholly owned subsidiary of Meditech
Pharmaceuticals, Inc, which spun off 2,156,855 shares to its shareholders as of
August 29, 2005.

The
Company is a development stage company as defined in Statement of Financial
Accounting Standards (SFAS) No. 7, Accounting and Reporting by
Development Stage Enterprises. The Company is devoting substantially all
of its present efforts to establish a new business, and its planned principal
operations have not yet commenced.

The
Company has not generated significant revenues from operations and has no
assurance of any future revenues. All losses accumulated since inception have
been considered as part of the Companys development stage activities. The
Company will require substantial additional funding for commercialization of its
products. There is no assurance that the Company will be able to obtain
sufficient additional funds when needed, or that such funds will be obtainable
on terms satisfactory to the Company. The Companys products, to the extent
that they may be deemed medical devices or biologics, are governed by the
Federal Food, Drug and Cosmetics Act and by the regulations of state agencies
and various foreign government agencies. There can be no assurance that the
Company will maintain or obtain the regulatory approvals required to market its
products.

Basis of
Presentation

The
accompanying financial statements have been prepared by EAST WEST pursuant to
the rules and regulations of the Securities and Exchange Commission. The
information furnished herein reflects all adjustments (consisting of normal
recurring accruals and adjustments) which are, in the opinion of managements,
necessary to fairly represent the operating results for the respective periods.
Certain information and footnote disclosures normally present in the annual
consolidated financial statements prepared in accordance with accounting
principles generally accepted in the United States of America have been omitted
pursuant to such rules and regulations. The results of the nine months ended
March 31, 2006 are not necessarily indicative of the results to be expected for
the full year ending June 30, 2006.

Estimates

The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosures of contingent assets and liabilities at the date of
the financial statements, as well as the reported amounts of revenues and
expenses during the reported period. Actual results could differ from those
estimates.

Cash and
Cash Equivalents

The
company considers all highly liquid investments purchased with an original
maturity of three months or less to be cash equivalents.

3



---

EAST
WEST DISTRIBUTORS, INC.

(Development
Stage Companies)

NOTES
TO FINANCIAL STATEMENTS

MARCH 31,
2006

(Unaudited)

Revenue

Revenue
represents license fees that are recognized when earned over the period of the
applicable license agreement.

Impairment
of Long-Lived Assets

The
Company reviews its long-lived assets for impairment whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be
recoverable. Recoverability of assets to be held and used is measured by a
comparison of the carrying amount of the assets to future net cash flows
expected to be generated by the assets. If the assets are considered to be
impaired, the impairment to be recognized is measured by the amount by which the
carrying amount exceeds the fair value of the assets. Based on its analysis, the
Company believes that no impairment of the carrying value on its long-lived
assets exists at March 31, 2006. There can be no assurance, however, that market
conditions will not change which could result in impairment of long-lived assets
in the future.

Stock-Based
Compensation

The
Company accounts for non-employee stock-based compensation under Statement of
Financial Accounting Standards No. 123 (SFAS 123), Accounting
for Stock-Based Compensation. SFAS 123 defines a fair value based method
of accounting for stock-based compensation. However, SFAS 123 allows an entity
to continue to measure compensation cost related to stock and stock options
issued to employees using the intrinsic method of accounting prescribed by
Accounting Principles Board Opinion No. 25 (APB 25),
Accounting for Stock Issued to Employees. Under APB 25, compensation
cost, if any, is recognized over the respective vesting period based on the
difference, on the date of grant, between the fair value of the Companys
common stock and the grant price. Entities electing to remain with the
accounting method of APB 25 must make pro forma disclosures of net income (loss)
and earnings per share, as if the fair value method of accounting defined in
SFAS 123 had been applied. The Company has elected to account for its
stock-based compensation to employees under APB 25.

For
purposes of pro forma disclosures, the estimated fair value of the options is
amortized to expense over the option vesting period. Adjustments are made for
options forfeited prior to vesting.

Income Taxes

The
Company recognizes deferred tax assets and liabilities for the expected future
tax consequences of events that have been included in the financial statements
or tax returns. Under this method, deferred income taxes are recognized for the
tax consequences in future years of differences between the tax bases of assets
and liabilities and their financial reporting amounts at each period end based
on enacted tax laws and statutory tax.

4



---

EAST
WEST DISTRIBUTORS, INC.

(Development
Stage Companies)

NOTES
TO FINANCIAL STATEMENTS

MARCH 31,
2006

(Unaudited)

rates
applicable to the periods in which the differences are expected to affect
taxable income. A valuation allowance is provided for significant deferred tax
assets when it is more likely than not those assets will not be recovered.

Loss Per
Share

Basic
loss per share is computed by dividing loss available to common stockholders by
the weighted-average number of common shares outstanding. Diluted loss per share
is computed similar to basic loss per share except that the denominator is
increased to include the number of additional common shares that would have been
outstanding if the potential common shares had been issued and if the additional
common shares were dilutive. For the nine months ended March 31, 2006, the
Company incurred net losses; therefore, potential common shares are ignored as
their effect would be anti-dilutive.

Comprehensive
Income

Comprehensive
income is not presented in the Companys consolidated financial statements
since the Company did not have any items of comprehensive income in any period
presented.

Segments of
an Enterprise and Related Information

As the
Company operates in one segment, the Company has not made segment disclosures in
the accompanying consolidated financial statements.

5



---

EAST
WEST DISTRIBUTORS, INC.

(Development
Stage Companies)

NOTES
TO FINANCIAL STATEMENTS

MARCH 31,
2006

(Unaudited)

NOTE B
 COMMITMENTS AND CONTINGENCIES

Leases

Currently,
the Company uses its operating facilities provided by its Chief Executive
Officer, without a lease agreement. There is no guarantee the officer will be
willing to provide these facilities in the future.

Employment
Agreements

There
are no employment agreements in effect as of March 31, 2006.

Litigation

The
Company may become involved in various legal proceedings and claims which arise
in the ordinary course of its business. Management does not believe that these
matters will have a material adverse effect on the Companys financial
position or results of operations.

6



---

EAST
WEST DISTRIBUTORS, INC.

(Development
Stage Companies)

NOTES
TO FINANCIAL STATEMENTS

MARCH 31,
2006

(Unaudited)

NOTE C
 STOCKHOLDERS DEFICIT

NOTE D 
RELATED PARTY TRANSACTIONS

The
Company maintains its primary place of business in facilities owned by the Chief
Executive Officer, for which it is NOT charged rent expense (see Note B).

7



---

Item 2.
Management's Discussion and Analysis of Financial Condition or Plan of Operation

You
should read the following discussion of our financial condition and operations
in conjunction with the condensed consolidated financial statements and the
related notes included elsewhere in this filing. This discussion contains
forward-looking statements that involve risks and uncertainties. Our actual
results may differ materially from those anticipated in these forward-looking
statements as a result of many factors.

Overview

We are
a drug development company, founded in 2004, focused in the areas of research,
development, and marketing in the biomedical industry, with an emphasis on
anti-infective drugs. The Company has been granted the rights to the drugs
Viraplex (R) and MTCH-24(TM).

Our
development activities since inception (December 14, 2004) have included efforts
to secure financing and create a management and business structure. These
activities have produced very little in operating revenues.

Going Concern

Our
financial statements for the nine months ended March 31, 2006, were prepared on
a going concern basis, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business. These factors,
among others, raise substantial doubt about our ability to continue as a going
concern.

We
must raise additional capital in order to continue and complete our research and
development and testing. Our future success is dependent upon raising additional
money to provide for the necessary operations of the Company. If we are unable
to obtain such additional financing, there would be a material adverse effect on
our business, financial position, and results of operations. Our continuation as
a going concern is dependent on our ability to generate sufficient capital to
meet our obligations on a timely basis, and to resume research and development
and testing efforts. However, no assurance can be given that additional capital,
if needed, will be available when required or upon terms acceptable to the
Company.

8



---

RESULTS OF
OPERATIONS FOR THE NINE MONTHS ENDED MARCH  31, 2006.

The
major activity during the first nine months of 2005  2006 was the sale of
the Companys 50% interest in BioDtech for $10,183.00. Other than that,
preparations were made to begin operations.

Operating
Expenses

Total
operating expenses consisted of legal and administrative costs in preparation
for commencement of operations in the amount of$66,182.00..

Net
Income/Loss

The
net loss for the nine months, of $55,999.00 was the result of
$66,182.00 in legal and administrative costs offset slightly by the sale
of the Companys 50% interest in BioDtech.

LIQUIDITY
AND CAPITAL RESOURCES

Our
cash and cash equivalents were $ 2,865.00 at March 31, 2006.

Item 3.   
Controls and Procedures

As of
the end of the period covered by this Form 10-QSB, the Company carried out an
evaluation, under the supervision and with the participation of its chief
executive officer and chief financial officer, of the effectiveness of the
design and operation of its disclosure controls and procedures (as defined in
Rule 13-a-15-e or 15-d-15-e under the Securities Exchange Act of 1934).

Based
on this evaluation, the Companys chief executive officer and chief
financial officer concluded that as of the evaluation date, such disclosure
controls and procedures were reasonably designed to ensure that information
required to be disclosed by the Company in reports it files or submits under the
Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the rules and forms of the Securities and Exchange
Commission.

Part II   
Other Information

Item 1.   Legal
Proceedings

Not applicable.

Item 2.   
Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3.    Defaults
Upon Senior Securities

Not applicable.

Item 4.   
Submission of Matters to a Vote of Security Holders

Not applicable.

9



---

Item 5.   
Other Information

Not applicable.

Item 6.   Exhibits

The
following exhibits are included herein:

|31.1 |  | Certification
of CEO Pursuant to Section 302 of the  Sarbanes-Oxley Act of 2002.
|---- |  | --------------------------------------------------------------------------------

|31.2 |  | Certification
of CFO Pursuant to Section 302 of the  Sarbanes-Oxley Act of 2002.
|---- |  | --------------------------------------------------------------------------------

|32.1 |  | Certification
of CEO Pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002.
|---- |  | --------------------------------------------------------------------------------

|32.2 |  | Certification
of CFO Pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002.
|---- |  | --------------------------------------------------------------------------------

Signatures

Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of
1934, the registrant has caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

EAST WEST
Distributors, Inc.

| | By:   
/s/   Gerald N. Kern
| | ---------------------------

| | Gerald
N.  Kern, Director(as of 05/1/06)
| | ----------------------------------------

| | Dated:   
5/1/06
| | ----------------

Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant and in the
capacities and/or the class indicated.

| | /s/   
Gerald N. Kern                      Dated: 5/1/06
| | --------------------------------------------------------

| | Gerald
N. Kern, Director(as of 5/1/06)
| | --------------------------------------

10